Multicompartmentalized microvascularized tumor-on-a-chip to study tumor-stroma interactions and drug resistance in ovarian cancer

Simona Plesselova,Kristin Calar,Hailey Axemaker,Emma Sahly,Pilar de la Puente

DOI: https://doi.org/10.1101/2024.05.29.596456

2024-06-02

Abstract:Introduction: The majority of ovarian cancer (OC) patients receiving standard of care chemotherapy develop chemoresistance within 5 years. The tumor microenvironment (TME) is a dynamic and influential player in disease progression and therapeutic response. However, there is a lack of models that allow us to elucidate the compartmentalized nature of TME in a controllable, yet physiologically relevant manner and its critical role in modulating drug resistance. Methods: We developed a 3D microvascularized multiniche tumor-on-a-chip formed by five chambers (central cancer chamber, flanked by two lateral stromal chambers and two external circulation chambers) to recapitulate OC-TME compartmentalization and study its influence on drug resistance. Stromal chambers included endothelial cells alone or cocultured with normal fibroblasts or cancer-associated fibroblasts (CAF). Results: The tumor-on-a-chip recapitulated spatial TME compartmentalization including vessel-like structure, stromal-mediated extracellular matrix (ECM) remodeling, generation of oxygen gradients, and delayed drug diffusion/penetration from the circulation chamber towards the cancer chamber. The cancer chamber mimicked metastasis-like migration and increased drug resistance to carboplatin/paclitaxel treatment in the presence of CAF when compared to normal fibroblasts. CAF-mediated drug resistance was rescued by ECM targeted therapy. Critically, these results demonstrate that cellular crosstalk recreation and spatial organization through compartmentalization are essential to determining the effect of the compartmentalized OC-TME on drug resistance. Conclusions: Our results present a functionally characterized microvascularized multiniche tumor-on-a-chip able to recapitulate TME compartmentalization influencing drug resistance. This technology holds the potential to guide the design of more effective and targeted therapeutic strategies to overcome chemoresistance in OC.

Bioengineering

What problem does this paper attempt to address?

The problem that this paper attempts to solve is that most ovarian cancer (OC) patients develop chemoresistance within 5 years after receiving standard - of - care chemotherapy. The tumor microenvironment (TME) plays a dynamic and important role in disease progression and treatment response, but currently there is a lack of models that can elucidate the compartmentalized nature of the TME and its crucial role in regulating drug resistance. Therefore, the researchers developed a multi - compartmentalized microvascularized tumor - on - a - chip to simulate the compartmentalization of the ovarian cancer TME and study its impact on drug resistance.

Specifically, the main objectives of this paper include:

1. **Develop a new physiologically relevant model**: This model can simulate the spatial organization and biological compartments of the ovarian cancer TME, especially through a multi - compartmentalized microvascularized tumor - on - a - chip.
2. **Study the impact of TME compartmentalization on drug resistance**: By culturing different cell types (such as endothelial cells, normal fibroblasts, and cancer - associated fibroblasts) in different compartments of the chip, study how the interactions between these cells affect drug penetration and efficacy.
3. **Verify the validity of the model**: Through a series of experiments, verify whether the model can successfully simulate the key features of the TME, such as angiogenesis, extracellular matrix (ECM) remodeling, formation of oxygen gradients, and drug penetration delay.

In summary, this paper aims to gain an in - depth understanding of the compartmentalized characteristics of the ovarian cancer TME and their impact on drug resistance by developing and validating a new type of multi - compartmentalized microvascularized tumor - on - a - chip, thereby providing theoretical basis and technical support for the design of more effective targeted treatment strategies.